ReviewThe oncologist2013
Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors.
Daniel J Lenihan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this paperpooled ittrialcites it